chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Couldn't eat while was sick; Slept all day; sick; Heavy duty arm pain and couldn't lift his arm over his ears; Shivering/chills; Muscle aches; Nausea; This is a spontaneous report from a contactable consumer. This consumer reported for a patient. A 69-year-old male patient (age at vaccination: 69 year) received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EW0172 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 10Jun2021 at 12:30, as a single dose for COVID-19 immunization. The patient's medical history included blood pressure, cholesterol, ongoing pulmonary issues, he had Covid, and residual problems. Concomitant medications were not reported. historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EW0172 and expiry date was not reported), via an unspecified route of administration, on 21May2021, as a single dose for COVID-19 immunization. The patient took Covid-19 Vaccine because he had a 98-year-old father and would like to see him. The patient had chills, shivering, muscle aches, nausea on 10Jun2021, and he slept all day on 11Jun2021. Saturday night he started to feel better. He was laid up from Thursday night until Saturday. He was in bed for almost 20 hours shivering. He was feeling better. He had Covid antibodies too. He needed to see people, and in order to see people he would only be embraced if he was vaccinated so he got the vaccine in order to be social. He was in bed freezing and sleeping. He had pretty heavy-duty arm pain and couldn't lift his arm over his ears. He started to complain of arm pain probably within 2 hours of the injection, and as more time passed the worse it got. At first it was like his arm was killing him, then he could barely lift his arm. By Thursday night he was shivering. In Arizona it was in the triple digits. He had 2 blankets, a comforter, and a sheet under than on him and he was shivering to the point where she had to lay on him to keep him warm. That lasted all night long and was just miserable. Then he got up for 5 or 10 minutes on Friday, then he was in bed the entire day until Saturday. It was unbelievable. They were so busy being sick they couldn't help each other. He looked pretty good by Saturday mid-morning at like 11:00 or so. The patient couldn't eat while was sick. On Saturday he made a cup of tea, toast, and an English muffin. He was definitely feeling better Saturday morning, and by Saturday afternoon he was pretty much himself. He was under a pulmonologist's care. He was seen by infection disease initially then he was put under the pulmonologist's care. He had X-rays to see how his lungs were doing, and they worked in conjugation with his primary physician. Outcome of the events was recovering.  Follow up attempts are possible further information is expected.
This spontaneous report as received from a nurse practitioner refers to a 13 months old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. On 02-JAN-2015, the patient was vaccinated with the dose of PEDVAXHIB lot # K008874 (dose, strength, route of administration and expiration date were not reported) which had temperature excursion (incorrect product storage). No information on patient's concomitant medication was provided. This is one of several reports from the same reporter. Additional information has been requested.
Moderate rash at site of injection; significant headache, body aches, slight nausea.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The pertinent medical history and concomitant medication was not reported. On 06-JUL-2015, the patient was vaccinated with unspecified number of improperly stored doses of M-M-R II (lot: K014833 and Expiry: 14-SEP-2016) (route unspecified). No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Patient given wrong vaccine. Patient was supposed to receive pneumovax 23. Has not developed adverse reactions yet.
Burning sensation started the next day after vaccination followed by hives all over left shoulder, about 4 days after a pus bubble formed, followed by a rash and the rash has been persistent since then. I finally saw a dermatologist on  1/22/2021 because there seem to be no improvement and it had been over 2 months of itching, burning and hives. I was prescribed Clobetasol and told to apply for 4 weeks I hope that this will resolve the reaction
Sore arm, fever, chills, body aches, hand sore and painful night and next day after vaccine.
8 hours after inoculation I experienced Shoulder/neck and back pain on RT side. "Stiff neck"  dx
Sore arm the next day; got what they expected; werent feeling well; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm the next day), ASTHENIA (got what they expected) and FEELING ABNORMAL (werent feeling well) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm the next day), ASTHENIA (got what they expected) and FEELING ABNORMAL (werent feeling well). At the time of the report, PAIN IN EXTREMITY (Sore arm the next day), ASTHENIA (got what they expected) and FEELING ABNORMAL (werent feeling well) outcome was unknown.            Treatment and concomitant medications were not provided by reporter.  Action taken with mRNA-1273 in response to the event was not applicable.    Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: NNI
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SEQUELA PERIPHERAL NEUROPATHY ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS ACUTE DVT OF BILAT ILIOFEMORAL VEINS
Vaccines given on 3/22/04.Parent called on 4/08/04 with complaints of pain, swelling, redness left upper arm. Symptoms increasing.Seen on 4/08/04 by MD and diagnosed with possible cellulitis. Put on Augmentin x 10 days.  Seen for follow-up on 4/12/04 with improvement.
Unusual symptoms due to a concussion; Never got the 2nd dose, Dr advised; This case was reported by a consumer and described the occurrence of concussion in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On 15th October 2018, the patient received the 1st dose of Shingrix. On an unknown date, not applicable after receiving Shingrix and less than a month after receiving Shingrix, the patient experienced concussion and incomplete course of vaccination. On an unknown date, the outcome of the concussion and incomplete course of vaccination were unknown.   The reporter considered the concussion to be unrelated to Shingrix.   Additional Information: GSK Receipt date: 12-JAN-2023 Reporter comment: The patient received 1st dose of shingrix and then patient doctor advised that not to get the second dose because patient was having some unusual symptoms nearly a month after that. The month later they found that the symptoms patient was experiencing were related to a concussion and not a reaction to the Shingrix, but then patient never received the second dose. The patient wanted to know if he/she get the second dose now after so much time time has elapsed. The reporter consented to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
She had breathing problems, bowel movement problems, sharp pain -site unknown No appetite and nausea.  Went to the Doctor on wednesday and they gave her a prescription for nausea (promethazine) 12.5mg She Passed away 03/12/2021 at 8:54pm waiting to be picked up by a friend that was going to take her to the emergency room/hospital.
Pt had localized reaction to left arm.  Redness and swelling.  Induration 40x60mm induration.
This spontaneous report as received from a registered nurse refers to a patient of unknown demographics. The concurrent condition and medical history was not reported. On 12-OCT-2010, the patient was vaccinated with GARDASIL dose 1. The concomitant medications were not reported. On 15-JUN-2015, the patient was vaccinated with GARDASIL dose 2 (inappropriate schedule of vaccine administration). Both the vaccines were confirmed to be GARDASIL and not GARDASIL 9. No adverse symptoms were reported. Additional information has been requested.
This spontaneous report was received from a medical assistant referring to a patients of unknown age and gender. No information was reported regarding the patients' medical history, concurrent conditions, concomitant medications, drug reactions, and allergies. On an unknown date, unspecified number of patients were vaccinated with improperly stored GARDASIL 9 (lot number: N021475 and expiration date: 31-JAN-2020) and ROTATEQ (lot number: N011648 and expiration date: 01-DEC-2018) (product storage error) for prophylaxis. The vaccines were exposed to temperature of 32 F to 35 Fahrenheit (F), below 32 F and as low as 27 F. Time frame was reported as multiple excursions over a period of 1 month. The call was because of a digital data logger. No adverse events were reported. Follow-up information was received from the medical assistant on 30-JAN-2018 regarding the temperature excursions of the vaccines. On 23rd of an unspecified month in 2017, 16-DEC-2017, 02-JAN-2018, and 03-JAN-2018, the vaccines of GARDASIL 9 were administered to unspecified number of patients. On 09-DEC-2017, the vaccines of GARDASIL 9 were exposed to temperature of 33.90 Fahrenheit for 15 minutes X 8 cycles, 120 minutes. Upon receipt of follow-up information it was determined that this case is now valid because patients identifiers were received. Follow up information has been received from a physician on 21-AUG-2018, referring to a 16 year old patient (gender not provided) who on 23-DEC-2017, was vaccinated with improperly stored dose of GARDASIL 9 (lot number: N021475 and expiration date: 31-JAN-2020), (strength, dose, frequency and route of administration were not provided). The vaccine was exposed to temperature of 32 F to 35 Fahrenheit (F), below 32 F and as low as 27 F. Time frame was reported as multiple excursions over a period of 1 month. The call was because of a digital data logger. No adverse events were reported. Sender's Comments: US-009507513-1801USA008060.
On 11/18/09 pt noticed a rectangular area of what appeared to be bug bites on the left side of her back. The next day she noticed similar bumps under her left breast and the ones on her back were spreading. She had mod. pain/itching of these areas. On 11/24/09 @ yearly check up - NP dx shingles. Started VALTREX and a cream and in 3 days it was much improved.
Patient experienced onset of vomiting, diarrhea, nausea approximately 24-48 hours post administration of MMR injection. Treated in ER for dehydration and released.
acute psychosis; This is a spontaneous report received from contactable reporter(s) (Physician) from a sales representative.  A female patient received BNT162b2 (COMIRNATY), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Comirnaty (DOSE 1, SINGLE), for Covid-19 immunization. Three weeks after the second dose, the patient was admitted to the hospital for acute psychosis.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The limited information provided in this report on this event of acute psychosis precludes a full assessment of the case. Medical history and concomitant medications are unknown. Clinical data and details about patient and suspect drug administration have not been provided. This case will be reassessed when additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
body aches; Sore arm; Mild Symptoms; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), PAIN IN EXTREMITY (Sore arm), GENERAL SYMPTOM (Mild Symptoms) and FATIGUE (fatigue) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, ENALAPRIL and TRAVOPROST for an unknown indication.   On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PAIN (body aches), PAIN IN EXTREMITY (Sore arm), GENERAL SYMPTOM (Mild Symptoms) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 13-Mar-2021, PAIN (body aches) and FATIGUE (fatigue) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm) and GENERAL SYMPTOM (Mild Symptoms) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.         Action taken with mRNA-1273 in response to the events were Not Applicable
50 y/o female, with no past medical history, who presents with itchy left arm, itchiness to different areas of her body and mild dizziness post vaccination administration. Patient also states that her left arm feels cold. Patient states that she is allergic to Aspirin and NSAIDS. This is the patients first vaccination which was applied to the left deltoid. NP and Paramedics at patient side. Patients legs were elevated, vitals taken and all within normal limits (SPO2 99% RA, 71 HR, 103/54 BP, 12 Resp). Patient provided with bottle of water and Benadryl PO administered x1. Patient was observed by the NP for improvement of symptoms. Patient with resolution of symptoms within 20 mins of medication administration. Patient was discharged home in stable condition.
Pt received Shingrex vaccination on Monday, Sept. 16, 2019 at pharmacy.  (pt originally reported she received the vaccination on the 17th, pharmacy then pt confirmed it was Monday, Sept 16, 2019).  Pt called her doctor's office on Friday, Sept. 20, 2019 to report her symptoms.  Reports by noon on the day she received the vaccine noted left arm soreness, by mid afternoon developed chills, excessive thirst, nausea, fatigue, required sips of water to help her swallow.  Symptoms continued all night, next AM awoke with headache, chills continued with nausea, and excessive fatigue. Tylenol relieved the headache. Next day chills decreased, fatigue started to improve, arm soreness left. Next day developed sores and pain under her tongue, developed bumps on her tongue.  Symptoms continued to improve, except for tongue and mouth sores and spots.  Chills were gone on day 4, fatigues improving, no nausea and thirst improved.   Today, Friday 9-20-19 chills, fatigue gone, soreness remains in mouth and tongue.  Denies ever experiencing a rash, itching, difficulty breathing or chest pressure/pain, no facial swelling.   First Shingrex received was at pharmacy (same) on 7-9-19 and experienced no adverse reactions.
patient fainted after giving last vaccination -Adacel. Patient was quickly revived in a few seconds.  We checked his blood pressure 102/67-pulse92. We had patient remain in pharmacy for 30 minutes to monitor him. He said he was fine and went home.
lARGE  LARGE, WARM, ITCHY REDNESS NOTICED ON 2/4/2021.  IS FADING AND ENLARGING, BUT STILL ITCHY TODAY ON 2/11/2021.
My shoulder pain was horrific. I could not lift my arm for a week. The pain was very intense and lasted a week. Any movement I would have stabbing pains. It has lessened down to a dull 8.
Diagnosed with myasthenia gravis; Difficulty swallowing; This case was reported by a pharmacist via call center representative and described the occurrence of myasthenia gravis in a 69-year-old male patient who received Herpes zoster (Shingrix) (batch number C3455, expiry date 3rd February 2023) for prophylaxis.   The patient's past medical history included swallowing difficult (had a history of difficulty swallowing food prior to vaccination with Shingrix).   On 20th December 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced myasthenia gravis (serious criteria GSK medically significant) and swallowing difficult. On an unknown date, the outcome of the myasthenia gravis and swallowing difficult were unknown.   It was unknown if the reporter considered the myasthenia gravis and swallowing difficult to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. After vaccination with dose of Shingrix, the patient was evaluated on 26th January 2022 for onset of difficulty swallowing and was diagnosed with myasthenia gravis. The reporter consented to follow up.
prone to passing out with vaccines so patient was placed in zero gravity chair to administer vaccine.  Patient passed out while laying in chair but regained consciousness soon after.  Water given and additional observation recommended
I started itching on my upper body then it moved all over from head to toe. I was getting bumps and rash on random places. Even the inside of my ears were itchy. I got red bumps and raised whelps where I touched and was hots. I contacted my doctor and was diagnosed with dermatographia. I am on Zyrtec now. The rash went away and the itching is still ongoing and I still have to take Zyrtec. I have Myalgic Encehalomyelitis and made a VAERS report on dose 2. I have more brain fog, fatigue, and could no longer function like I use to. I am now on disability. My nervous system and anxiety is worse. I was sleeping poorly and lost my appetite. I have bloating as well.
Gave HPV, VAR in (R) arm. Immediately after giving Hep A in (L) del, patient became limp, (remained sitting up), eyes briefly rolled back, had a few general jerking motions, stood up, eyes open, moaned and was unresponsive. Lasted approx 30 seconds, possibly less. Then said "What happened?" Instructed to sit on the floor. VSS monitored. Mid level practitioner eval, EMS called. Not transported.
Intense chills started about 5 hours after vaccine injection and lasted on/off through the night.  Fever at 9 pm was 102 degrees.  Felt tired but chills and fever were gone by morning and felt relatively back to normal.
I had all the side effects listed in the moderna education sheet... fever 101, body aches, chills but I had SEVERE night terrors the first night after the shot. The were terrifying. I have never had them in the past. My husband would have to wake me up and i was screaming in my sleep.   I am an Infection Prevention Director for a large  health system. I have worked the COVID pandemic since its conception. I am also involved in the COVID vaccination rollout for our employees and community. I still plan on receiving the second dose next week.
The flu shot was given on 10/18/06. The next morning, there was severe pain in the shoulder which felt like the muscle was torn or out of the socket. This lasted for 4 days. The pain started to decrease for 2 days On 10/25/06, woke up with excruciation pain, described as sharp, knife pain, with burning, radiating pain from the should to the elbow. Additionally, there was deep inside the bone pain. Went to the doctor on 11/01/06 was told to apply heat and take ibuprofen. On  11/3/06 and 11/4/06 ran a temp of 100.5 with body aches, sore throat and splotchy hives on stomach and chest (which started before the temp). The arm pain continues and seemed to be amplified by the fever. 11/05/06 no temp. 11/07 no sore throat. The intense pain is decreasing. The arm now feels weak and with muscle pain on the inside and outside of the arm. Arm mobility and range is limited due to pain.
Very painful left arm, felt the tip of my tongue tingling and my lips swelling slightly within 6 hrs of the vaccine. Developed mouth sores along the sides of my tongue and inside my lips, and back of throat, and a fever blister within a few days of the vaccine
190 patients (9 different lot numbers) received a vaccine past the beyond used by date; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    It was unknown if patient received any other vaccines in the 4 weeks prior to the COVID-19 vaccine administration.  No concomitant medication was reported. No treatment medication was reported.  This case pertains to the 120th patient of the total 190 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335:MASTER CASE
10/1/02 Patient complains of cramps in abdomen and diarrhea. 10/14/02 Mother believes symptoms are due to vaccine. Referred to GI specialist.
Fever, chills, unaware of surrounding, delirium- time frame from approximately 11:15 am to 4:30pm . She was by herself, discovered after a phone call to check on her
Headache followed by fever and sweats. Vomiting and diarrhea (each twice) then chills. And then it was over. About 2 hours total for the event.
Narrative:  Timing ERROR only, 2nd dose given 66 days after 1st.
Bell's palsy one day after receiving DTaP. Rx: Acyclovir, oral med - resolved in one week.